Related Experiment Videos
Interaction of enkephalin peptides with anionic model membranes
Marek Romanowski1, Xiaoyun Zhu, Kathy Kim
1Department of Chemistry, University of Arizona, Tucson 85721, USA.
Biochimica Et Biophysica Acta
|December 26, 2001
Summary
Membrane surface charge significantly impacts peptide drug transport. Increased negative charge hinders cationic peptide permeability by reducing diffusion, affecting drug delivery. This highlights the role of electrostatic interactions in membrane transport.
Area of Science:
- Biophysics
- Pharmacology
- Membrane Biology
Background:
- Passive transport across biological membranes is crucial for drug delivery.
- Membrane surface charge is a key factor influencing molecular interactions and transport.
- Understanding peptide-membrane interactions is vital for developing effective peptide-based therapeutics.
Purpose of the Study:
- To investigate the effect of membrane surface charge on the permeability and interaction of analgesic peptide ligands.
- To elucidate the role of electrostatic interactions in peptide-membrane transport.
- To assess the potential impact of natural cell membrane charge on peptide drug delivery.
Main Methods:
- Utilized model membranes composed of zwitterionic phospholipids and cholesterol.
- Controlled membrane surface charge density by incorporating anionic lipids.
- Studied the permeability and binding of two potent analgesic peptides: c[D-Pen(2),D-Pen(5)]enkephalin (DPDPE) and biphalin.
Main Results:
- Increased negative surface charge moderately decreased the permeability of zwitterionic DPDPE, attributed to a reduced partition coefficient.
- The binding of dicationic biphalin ligands to membranes increased with higher negative surface charge.
- This enhanced binding significantly reduced biphalin permeability by impeding its diffusion across the lipid bilayer.
Conclusions:
- Electrostatic effects play a critical role in peptide-membrane interactions.
- The negative charge of cell membranes may impede the transport of cationic peptide drugs.
- Targeted strategies or transporters may be necessary to overcome charge-related transport barriers for certain peptide therapeutics.